Procainamide hydrochloride

This page contains recent news articles, when available, and an overview of Procainamide hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

… Code - 77 Ill. Adm. Code 790.7500 PROCAINAMIDE HYDROCHLORIDE …  -  Aug 10, 2005
77 Ill. Adm. Code 790.7500 PROCAINAMIDE HYDROCHLORIDE (Repealed) Repealed. (Source: Repealed at 17 Ill. Reg. 15916, effective September 20, 1993) ... Pay-Per-View - Illinois Administrative Code - Loislaw

New Jersey Administrative Code - 8:41-6.1 Medications and therapeutic...  -  Aug 16, 2005
Procainamide hydrochloride; 30. Sodium bicarbonate; 31. Sodium thiosulfate; 32. Succinylcholine; 33. Terbutaline sulfate; 34. Vasopressin; 35. ... Pay-Per-View - New Jersey Administrative Code - Loislaw

Doppler sonographic evaluation of left atrial function after cardiover...  -  Jun 1, 2006
Seventy patients were randomly chosen to undergo cardioversion by either direct current shock or intravenously administered procainamide hydrochloride. ... Journal of Ultrasound in Medicine...

Merger and Acquisition Scenario  -  Nov 25, 2006
Target (Total: 68). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

King Pharmaceuticals Completes Review Of Returns Reserve.  -  Feb 22, 2005
...of intangible assets associated with Tapazole(R) (methimazole tablets, USP) and Procanbid(R) (procainamide hydrochloride extended-release tablets). ... $4.95 - PR Newswire - ECNext

Merger and Acquisition Scenario  -  Dec 16, 2006
Buyer (Total: 68). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 27, 2007
Buyer (Total: 70). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  May 19, 2007
Target (Total: 70). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Feb 23, 2008
Buyer (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 22, 2008
Buyer (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 15, 2008
Buyer (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 21, 2007
Buyer (Total: 70). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Press Release: King Pharmaceuticals Completes Review Of Returns …  -  Feb 22, 2005
...of intangible assets associated with Tapazole(R) (methimazole tablets, USP) and Procanbid(R) (procainamide hydrochloride extended-release tablets). ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Apr 7, 2007
Buyer (Total: 70). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Buyer (Total: 66). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 15, 2008
Buyer (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Target (Total: 66). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 8, 2008
Target (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 8, 2007
Buyer (Total: 66). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 26, 2008
Target (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jul 14, 2007
Buyer (Total: 70). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 4, 2006
Buyer (Total: 68). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 24, 2007
Buyer (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 15, 2006
Target (Total: 78). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 5, 2008
Target (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 8, 2007
Buyer (Total: 66). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 16, 2006
Target (Total: 68). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 26, 2008
Buyer (Total: 65). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 11, 2006
Buyer (Total: 78). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 8, 2007
Buyer (Total: 66). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  May 13, 2006
Buyer (Total: 78). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jun 16, 2007
Target (Total: 70). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jun 24, 2006
Target (Total: 78). Adrenalin Chloride Solution (Epinephrine); Corgard (Nadolol); Adenocard (Adenosine); Procanbid (Procainamide Hydrochloride) ... $250.00 - Revere Reports - Revere





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy